Cost-utility analysis of relapsing-remitting multiple sclerosis treatment with azathioprine or interferon beta in Spain

  1. Rubio-Terrés, C.
  2. Domínguez-Gil Hurlé, A.
Aldizkaria:
Revista de Neurologia

ISSN: 0210-0010

Argitalpen urtea: 2005

Alea: 40

Zenbakia: 12

Orrialdeak: 705-710

Mota: Artikulua

DOI: 10.33588/RN.4012.2004417 GOOGLE SCHOLAR
Datuen iturria: Scopus